QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ZLAB

QT54Zai Lab Limited
NASDAQ·Healthcare·Biotechnology·China
Latest market price
18.18
+0.30+1.68%
OverviewShort InterestFilings
ZLABQT54Zai Lab Limited·NASDAQ
OverviewShort InterestFilings
18.18+1.68%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-1.66
Insider Own0.29%
Shs Outstand1.13B
Perf Week3.06%
Market Cap2.06BForward P/E-EPS next Y-1.70Insider Trans0.13%Shs Float-Perf Month-1.03%
Enterprise Value1.54BPEG-EPS next Q-0.67Inst Own-Short Float-Perf Quarter-2.31%
Income-180867606.00P/S4.55EPS this Y-25.97%Inst Trans-Short Ratio-Perf Half Y6.94%
Sales452.86MP/B3.06EPS next Y18.81%ROA-16.23%Short Interest-Perf YTD3.06%
Book/sh0.58P/C-EPS next 5Y-ROE-24.29%52W High41.20 -55.87%Perf Year-51.16%
Cash/sh0.58P/FCF-EPS past 3/5Y-ROIC-26.03%52W Low15.96 13.91%Perf 3Y-
Dividend Est.-EV/EBITDA-7.96Sales past 3/5Y28.86% 56.50%Gross Margin57.91%Volatility3.49% 3.27%Perf 5Y-
Dividend TTM-EV/Sales3.41EPS Y/Y TTM37.69%Oper. Margin-53.49%ATR (14)0.86Perf 10Y-
Dividend Ex-Date-Quick Ratio2.19Sales Y/Y TTM13.78%Profit Margin-39.29%RSI (14)49.81Recom2.18
Dividend Gr. 3/5Y-Current Ratio2.40EPS Q/Q-2.22%SMA203.00%Beta1.08Target Price35.00
Payout0.00%Debt/Eq0.35Sales Q/Q-5.66%SMA50-8.36%Rel Volume1.12Prev Close17.88
Employees1,869LT Debt/Eq0.02EarningsAug 06SMA200-16.67%Avg Volume875.64KPrice18.18
IPO DateSep 20, 2017Option/ShortYes / YesEPS/Sales Surpr.12.57% -7.41%Net Debt/EBITDA2.68Volume978,129Change1.68%
Analyst Ratings
DateActionAnalystRatingTarget
Jan-07-26InitiatedUBSBuy$35
Jun-30-25ReiteratedLeerink PartnersOutperform$101 → $75
Mar-07-25InitiatedScotiabankOutperform$55
Mar-03-25DowngradeB of A SecuritiesBuy → Neutral
Sep-27-24ReiteratedMorgan Stanley$50
Apr-21-22ReiteratedLeerink Partners$101
Latest News
Jun-16-26
Jun-16-2607:14AM
Zai Lab Announces EMA Grants Orphan Drug Designation To Zocilurtatug Pelitecan, Delta-Like Ligand 3-Targeting Antibody-Drug Conjugate, For Treatment Of Pulmonary Neuroendocrine CarcinomasBenzinga
Jun-10-26
Jun-10-2602:36PM
Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday TradingYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue454460399
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A190191148
Gross Profit262269251
Selling, General and Administrative Excl. Other279278299
Research and Development227221235
Other Operating Expense0-6-1
Operating Income-242-224-282
Interest Expense552
Unusual Expense
———
Non-Operating Income (Expense)-67-50-27
Net Income Before Taxes-180-178-257
Income Taxes-2-30
Consolidated Net Income-178-176-257
Net Income From Continuing Operations-178-176-257
Net Income-178-176-257
EPS (Recurring)-1.66-1.60-2.60
EPS (Basic, Before Extraordinaries)-1.66-1.60-2.60
EPS (Diluted)-1.66-1.60-2.60
EBITDA-159-158-235
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio4.444.22—
Gross Margin57.7158.4862.91
Operating Margin-53.30-48.70-70.68
Net Margin-39.21-38.26-64.41
Shares Outstanding11111099
Market Capitalization2,0181,940—
Operating Lease Expense
———
Insider Trading Volume
$19.20$17.46$15.72$13.98$12.24● Close Price0.00M1.86M3.72M5.57M7.43MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Du YingChairperson & CEOMay 19 '26Option Exercise1.74522,184908,6001,383,718May 21 12:00 AM
Du YingChairperson & CEOMay 18 '26Option Exercise1.74100,000174,0001,172,626May 19 12:00 AM
Du YingChairperson & CEOMay 18 '26Sale19.0050,000949,7651,122,626May 19 12:00 AM
Du YingChairperson & CEOMay 15 '26Option Exercise1.7450,00087,000311,092May 19 12:00 AM
Du YingChairperson & CEOMay 15 '26Sale20.7450,0001,037,1101,122,626May 19 12:00 AM
Edmondson Frazor Titus IIIChief Legal OfficerMay 14 '26Sale20.193,51771,00819,849May 15 12:00 AM
Du YingChairperson & CEOMay 14 '26Sale20.0950,0001,004,5751,122,626May 15 12:00 AM
Du YingChairperson & CEOMay 14 '26Option Exercise1.74100,000174,0001,172,626May 15 12:00 AM
Du YingChairperson & CEOMay 13 '26Option Exercise1.7450,00087,000411,092May 15 12:00 AM
Du YingChairperson & CEOMay 13 '26Sale19.9750,000998,4701,122,626May 15 12:00 AM
Du YingChairperson & CEOApr 06 '26Sale20.452,65354,2491,122,626Apr 08 12:00 AM
Chen YajingChief Financial OfficerApr 06 '26Sale20.4585317,44231,705Apr 08 12:00 AM
Amado RafaelSee RemarksApr 06 '26Sale20.452,73956,00757,022Apr 08 12:00 AM
Smiley Joshua LSee RemarksApr 06 '26Sale20.453,01761,692117,602Apr 08 12:00 AM
Edmondson Frazor Titus IIIChief Legal OfficerApr 06 '26Sale20.451,22425,02823,366Apr 08 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR